Differences in the Prognostic Significance of the SUVmax between Patients with Resected Pulmonary Adenocarcinoma and Squamous Cell Carcinoma |
Motono, Nozomu
(Department of Thoracic Surgery, Kanazawa Medical University)
Ueno, Masakatsu (Department of Thoracic Surgery, Kanazawa Medical University) Tanaka, Makoto (Department of Thoracic Surgery, Kanazawa Medical University) Machida, Yuichiro (Department of Thoracic Surgery, Kanazawa Medical University) Usuda, Katsuo (Department of Thoracic Surgery, Kanazawa Medical University) Sakuma, Tsutomu (Department of Thoracic Surgery, Kanazawa Medical University) Sagawa, Motoyasu (Department of Thoracic Surgery, Kanazawa Medical University) |
1 | Alberts W (2007). Follow up and surveillance of the patient with lung cancer: What do you do after surgery? Respirology, 12, 16-21. DOI |
2 | Al-Jahdali H, Khan AN, Loutfi S, Al-Harbi AS (2012). Guidelines for the role of FDG-PET/CT in lung cancer management. J Infect Public Health, 5, 35-40. DOI |
3 | Al-Sarraf N, Gately K, Lucey J, et al (2008). Clinical implication and prognostic significance of standardized uptake value of primary non-small cell lung cancer on positron emission tomography:analysis of 176 cases. Eur J Cardiothorac Surg, 34, 892-7. DOI ScienceOn |
4 | de Geus-Oei LF, van der Heijden H, Corstens F, Oyen W (2007). Predictive and prognostic value of FDG-PET in nonsmallcell lung cancer. Cancer, 110, 1654-64. DOI |
5 | Ding XP, Zhang J, Li BS, et al (2012). Feasibility of shrinking field radiation therapy through 18F-FDG PET/CT after 40 Gy for stage III non-small cell lung cancers. Asian Pac J Cancer Prev, 13, 319-23. 과학기술학회마을 DOI ScienceOn |
6 | Hasbek Z, Yucel B, Salk I, et al (2014). Potential impact of atelectasis and primary tumor glycolysis on F-18 FDG PET/ CT on survival in lung cancer patients. Asian Pac J Cancer Prev, 15, 4085-9. 과학기술학회마을 DOI |
7 | Hicks RJ, Kaiff V, MacManus MP, et al (2001). The utility of 18F-FDG PET for suspected recurrence non-small cell lung cancer after potentially curative therapy: Impact on management and prognostic stratification. J Nucl Med, 42, 1605-13. |
8 | Higashi K, Ueda Y, Arisaka Y, et al (2002). 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med, 43, 39-45. |
9 | Higuchi M, Hasegawa T, Osugi J, Suzuki H, Gotoh M (2014). Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma. Ann Thorac Cardiovasc Surg, 20, 185-91. DOI |
10 | Hoekstra C, Stroobants S, Smit E, et al (2005). Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-d-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. J Clin Oncol, 23, 8362-70. DOI |
11 | Kaya AO, Coskun Y, Unlu M, et al (2008). Whole body 18F-FDG PET/CT imaging in the detection of primary tumors in patients with a metastatic carcinoma of unknown origin. Asian Pac J Cancer Prev, 9, 683-6. |
12 | Mutlu H, Buyukcelik A, Erden A, et al (2013). Staging with PET-CT in patients with locally advanced non small cell lung cancer is superior to conventional staging methods in terms of survival. Asian Pac J Cancer Prev, 14, 3743-6. 과학기술학회마을 DOI ScienceOn |
13 | Liu NB, Zhu L, Li MH, et al (2013). Diagnostic value of 18F-FDG PET/CT in comparison to bone scintigraphy, CT and 18F-FDG PET for the detection of bone metastasis. Asian Pac J Cancer Prev, 14, 3647-52. 과학기술학회마을 DOI ScienceOn |
14 | Mac Manus MP, Hicks RJ, Matthews JP, et al (2003). Positron emission tomography is superior to computed tomography scaning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. J Clin Oncol, 21, 1285-92. DOI |
15 | Martini N, Bains M, Burt M, et al (1995). Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg, 109, 120-9. DOI |
16 | Patz EF Jr, Connolly J, Herndon J (2000). Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. AJR, 174, 769-74. DOI |
17 | Sasaki R, Komaki R, Macapinlac H, et al (2005). [18F] Fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol, 23, 1136-43. DOI |
18 | Shiono S, Abiko M, Okazaki T, et al (2011) Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake value. Eur J Cardiothorac Surg, 40, 1165-9. |
19 | Vansteekiste JF, Stroobants SG, Dupont PJ, et al (1999). Prognostic importance of the standardized uptake value on 18F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer. An analysis of 125 cases. J Clin Oncol, 17, 3201-6. |
20 | Sugimura H, Nichols F, Yang P, et al (2007). Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg, 83, 409-18. DOI ScienceOn |
21 | Walsh G, O'Connor M, Willis K, et al (1995). Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg, 60, 1563-72. DOI |
22 | Zhu SH, Zhang Y, Yu YH, et al (2013). FDG PET-CT in nonsmall cell lung cancer: relationship between primary tumor FDG uptake and extensional or metastatic potential. Asian Pac J Cancer Prev, 14, 2925-9. DOI ScienceOn |